Navigation Links
Sub-Cell GT System, with tray

ProductsSub-Cell GT System, with tray
Company Bio-Rad Lab Equipment
Item Sub-Cell GT System, with tray
Features 
  • UV-transparent gel trays with fluorescent ruler
  • Gel-casting gates for casting gels in the electrophoresis cell
  • A gel caster that allows tape-free casting of multiple gels and sizes simultaneously
  • Easy-to-replace electrode cassettes
Description Submerged horizontal gels offer many advantages for nucleic acid separation, and have become a primary tool for the molecular biologist. Agarose gels are easy to cast and readily dissipate heat. These gels allow sample underlaying and prevent electrical field discontinuities caused by wicks or sample well dehydration. Horizontal systems are more economical and easier to use than vertical systems.
Info Bio-Rad Lab Equipment
Customer Service: 510-741-5790
Web site: http://www.bio-rad.com/

Related medicine products :

1. Wide Mini ReadySub-Cell GT Cell
2. Mini ReadySub-Cell GT Cell
3. Sub-Cell GT System, with tray and gel caster
4. Proven Cruciate Retaining Knee System, standard
5. Proven Cruciate Retaining Knee System, curved
6. HemoCue 201 DM System, Hb
7. HemoCue 201 DM System, Glucose
8. Mini-TAG™ System, 2.0 mm
9. Mini-TAG™ System, 3.0 mm
10. Ogden™ Soft Tissue Anchor System, Non-Sterile
11. Ogden™ Soft Tissue Anchor System, Sterile Packs
Breaking Medicine Technology:Heska Announces Extension of Credit Agreement With Wells Fargo 2Heska Announces Extension of Credit Agreement With Wells Fargo 3Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 1Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 2Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 3Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 4Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 5Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 6Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 7Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 8Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 9Golden Meditech Announces HK 24217 Million Private Equity Financing for Hospital Subsidiary 14309 1Golden Meditech Announces HK 24217 Million Private Equity Financing for Hospital Subsidiary 14309 2Method to Identify Female Athletes at a High Risk for Knee Injury Discovered 58628 1Method to Identify Female Athletes at a High Risk for Knee Injury Discovered 58628 2